Fatty liver disease exists on a spectrum from simple fatty liver (NAFLD) to an inflamed fatty liver (NASH). In the United States, the prevalence of fatty liver disease ranges from 10-46% percent, and liver biopsy-based studies report a prevalence of NASH of 1-17%. Systematic reviews suggest NAFLD prevalence in adults is probably 25-33%, while NASH prevalence is 2-5%. Generally speaking, patients with the more advanced lesions of NASH are at risk for developing scar tissue in the liver (fibrosis) which can progress to cirrhosis and end-stage liver disease. Therefore, monitoring liver function has become an indispensable part of daily life.
Konsung portable dry biochemical analyzer adopts optical detection method, which assure the clinical standard accuracy (CV≤5%). It only requires 45μL of fingertip blood, the value of ALB, ALT and AST will be tested within 3 min and the test results show on the 4.3 touch screen. The storage of 3000 test results provides great convenience for monitoring liver function in daily life.
Konsung medical, focus on more details of your #healthcare.
Post time: Mar-24-2022